Urethritis

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 1349.e1-1357.e2

  Augenbraun, Michael H ^a   McCormack, William M ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

Chlamydia trachomatis; Discharge; Epididymitis; Mycoplasma genitalium; Neisseria gonorrhoeae; NGU (nongonococcal urethritis); Nucleic acid amplification; Postgonococcal urethritis; Pyuria; Reactive arthritis; Sexually acquired reactive arthritis; Sexually transmitted diseases; STD; Trichomonas vaginalis; Trichomoniasis

Indexed keywords

EID: 84944524621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00109-0     Document Type: Chapter

References (159)

1. Taylor-Robinson D The history of nongonococcal urethritis. Thomas Parran Award Lecture. Sex Transm Dis 1996, 23:86-91.
2. Geisler WM, Yu S, Hook EW Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on Gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005, 32:630-634.
3. Smith R, Copas AJ, Prince M, et al. Poor sensitivity and consistency for microscopy in the diagnosis of low grade non-gonococcal urethritis. Sex Transm Infect 2003, 79:487-490.
4. Jacobs NF, Kraus SJ Gonococcal and nongonococcal urethritis in men: clinical and laboratory differentiation. Ann Intern Med 1975, 82:7-12.
5. Haberberger RL, Mikhail IA, Fox E, et al. Predominance of vancomycin-sensitive strains of Neisseria gonorrhoeae in Djibouti. Lancet 1989, 2:683.
6. Krieger JN, Verdon M, Siegel N, et al. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992, 166:1362-1366.
7. Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993, 118:844-849.
8. Schwebke J, Hobbs M, Taylor S, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective US clinical trial. J Clin Microbiol 2001, 49:4106-4111.
9. Wiggins RC, Holmes CH, Andersson M, et al. Quantifying leukocytes in first catch urine provides new insights into our understanding of symptomatic and asymptomatic urethritis. Int J STD AIDS 2006, 17:289-295.
10. Horner PJ, Taylor-Robinson D Is there a role for leucocytes esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men?. Int J STD AIDS 2007, 18:73-74.
11. Hobbs MM, Lapple DM, Lawing LF, et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol 2006, 44:3994-3999.
12. Puolakkainen M, Hiltunen-Back E, Reunala T, et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998, 36:1489-1493.
13. Jaschek G, Gaydos CA, Welsh LE, et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993, 31:1209-1212.
14. Chernesky M, Jang D, Chong S, et al. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infection in men. Sex Transm Dis 2003, 30:345-347.
15. Martin DH Nongonococcal urethritis: new views through the prism of modern molecular microbiology. Curr Infect Dis Rep 2008, 10:128-132.
16. Augenbraun MH, Cummings M, McCormack WM Management of chronic urethral symptoms in men. Clin Infect Dis 1992, 15:714-715.
17. Pec J, Straka S, Novomesky F, et al. Mechanical urethritis and ascendant genitourinary infections due to sexual stimulation of the urethra by inserted foreign bodies. Genitourin Med 1992, 68:399-400.
18. Al-Sweih N, Khan S, Rotimi V The prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among men with urethritis in Kuwait. J Infect Public Health 2011, 4:175-179.
19. Le Roux M, Ramoncha M, Adam A, et al. Aetiological agents of urethritis in symptomatic South African men attending a family practice. Int J STD AIDS 2010, 21:477-481.
20. Ciemins EL, Flood J, Kent CK, et al. Reexamining the prevalence of Chlamydia trachomatis infection among gay men with urethritis: implications for STD policy and HIV prevention activities. Sex Transm Dis 2000, 27:249-251.
21. Stamm WE, Koutsky LA, Benedetti JK, et al. Chlamydia trachomatis urethral infections in men: prevalence, risk factors, and clinical manifestations. Ann Intern Med 1984, 100:47-51.
22. Mimiaga M, Helms D, Reisner S, et al. Gonococcal, Chlamydia and syphilis infection positivity among MSM attending a large primary care clinic, Boston, 2003 to 2004. Sex Transm Dis 2009, 36:507-511.
23. Lafferty WE, Hughes JP, Handsfield HH Sexually trans-mitted diseases in men who have sex with men: acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997, 24:272-278.
24. Schwartz MA, Lafferty WE, Hughes JP, et al. Risk factors for urethritis in heterosexual men: the role of fellatio and other sexual practices. Sex Transm Dis 1997, 24:449-455.
25. Sadiq ST, Taylor S, Copas AJ, et al. The effects on urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. Sex Transm Infect 2005, 81:120-123.
26. Boyd JT, Csonka GW, Oates JK Epidemiology of non-specific urethritis. Br J Vener Dis 1958, 34:40-43.
27. Rothenberg R, Judson FN The clinical diagnosis of urethral discharge. Sex Transm Dis 1983, 10:24-28.
28. Lee Y-H, Rosner B, Alpert S, et al. Clinical and microbiological investigation of men with urethritis. J Infect Dis 1978, 138:798-803.
29. Holmes KK Gonococcal infection: clinical, epidemiologic and laboratory perspectives. Adv Intern Med 1974, 19:259-285.
30. Oriel JD Treatment of nongonococcal urethritis. Nongonococcal Urethritis and Related Infections 1977, 38-42. American Society for Microbiology, Washington, DC. D. Hobson, K.K. Holmes (Eds.).
31. Johannisson G, Lowhagen G-B, Nilsson S Chlamydia trachomatis and urethritis in men. Scand J Infect Dis 1982, 32(suppl):87-92.
32. Bradshaw C, Tabrizi S, Read T, et al. Etiologies of nongonococcal urethritis: bacteria, viruses and the association with orogenital exposure. J Infect Dis 2006, 193:336-345.
33. Kurahashii T, Miyake H, Nakano Y, et al. A comparison of clinical features between chlamydial and non-chlamydial urethritis in men negative for gonococci infection who attended a urological outpatient clinic in Japan. Int Urol Nephrol 2007, 39:809-813.
34. Deguchi T, Yoshida T, Miyazawa T, et al. Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis. Sex Transm Dis 2004, 31:192-195.
35. Yoshida T, Deguchi T, Meda S, et al. Quantitative detection of Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens from men with and without urethritis by real-time polymerase chain reaction. Sex Transm Dis 2007, 34:416-419.
36. Couldwell C, Gidding H, Freedman E, et al. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS 2010, 21:337-341.
37. Taylor-Robinson D, McCormack WM The genital mycoplasmas. N Engl J Med 1980, 302:1003-1010.
38. Tully JG, Cole RM, Taylor-Robinson D, et al. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981, 1:1288-1291.
39. Anagrius C, Lore B, Jensen JS Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005, 81:458-462.
40. Mena L, Wang X, Mroczkowski TF, et al. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis 2002, 35:1167-1173.
41. Manhart L, Broad J, Golden M Mycoplasma genitalium: should we treat and how?. Clin Infect Dis 2011, 53(suppl 3):S129-S142.
42. Stimson JB, Hale J, Bowie WR, et al. Tetracycline-resistant Ureaplasma urealyticum: a cause of persistent nongonococcal urethritis. Ann Intern Med 1981, 94:192-194.
43. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infection: clinical manifestations, course, and complications. Ann Intern Med 1983, 98:958-972.
44. Schwebke JR, Hook EW High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003, 188:465-468.
45. Wendel KA, Erbelding EJ, Gaydos CA, et al. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003, 79:151-153.
46. Nacey JN, Tulloch AGS, Ferguson AF Catheter-induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. Br J Urol 1985, 57:325-328.
47. Conde-Glez CJ, Calderon E Urogenital infection due to meningococcus in men and women. Sex Transm Dis 1991, 18:72-75.
48. Abdolrasouli A, Amin A, Baharsefat M, et al. Moraxella catarrhalis associated with acute urethritis imitating gonorrhoeae acquired by oral-genital contact. Int J STD AIDS 2007, 18:579-580.
49. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006, 193:336-345.
50. Handsfield HH Nongonococcal urethritis: a few answers but mostly questions. J Infect Dis 2006, 193:333-335.
51. Yokoi S, Maeda S, Kubota Y, et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007, 45:866-871.
52. Ivanov YB Microbiological features of persistent nonspecific urethritis in men. J Microbiol Immunol Infect 2007, 40:157-161.
53. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984, 310:545-549.
54. Handsfield HH, Lipman TO, Harnisch JP, et al. Asymptomatic gonorrhea in men: diagnosis, natural course, prevalence and significance. N Engl J Med 1974, 290:117-123.
55. Detels R, Green A, Klausner J, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis 2011, 38:503-509.
56. Stamm WE Etiology and management of the acute urethral syndrome. Sex Transm Dis 1981, 8:235-238.
57. Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980, 303:409-414.
58. Fihn SD, Johnson C, Stamm WE Escherichia coli urethritis in women with symptoms of acute urinary tract infection. J Infect Dis 1988, 157:196-199.
59. Curran JW Gonorrhea and the urethral syndrome. Sex Transm Dis 1977, 4:119-121.
60. Paavonen J Chlamydia trachomatis-induced urethritis in female partners of men with nongonococcal urethritis. Sex Transm Dis 1979, 6:69-71.
61. Berger RE Acute epididymitis. Sex Transm Dis 1981, 8:286-289.
62. Ness RB, Markovic N, Carlson CL, et al. Do men become infertile after having sexually transmitted urethritis? An epidemiologic examination. Fertil Steril 1997, 68:205-213.
63. Holmes KK, Hansfield HH, Wang SP, et al. Etiology of nongonococcal urethritis. N Engl J Med 1975, 292:1199-1205.
64. Krieger JN, Riley DE Chronic prostatitis: Charlottesville to Seattle. J Urol 2004, 172:2557-2560.
65. Ronnerstam R, Persson K Chlamydial eye infection in adults. Scand J Infect Dis 1982, 32(suppl):111-115.
66. Workowski KA, Berman S Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010, 59(RR-12):1-110. Centers for Disease Control and Prevention.
67. Bowie WR, Yu JS, Fawcett A, et al. Tetracycline in nongonococcal urethritis: comparison of 2 g and 1 g daily for seven days. Br J Vener Dis 1980, 56:332-336.
68. Augenbraun M, Bachmann L, Wallace T, et al. Compliance with doxycycline therapy in sexually transmitted disease clinics. Sex Transm Dis 1998, 25:1-4.
69. Krieger JN, Hooton TM, Brust PJ, et al. Evaluation of chronic urethritis: defining the role for endoscopic procedures. Arch Intern Med 1988, 148:703-707.
70. Centers for Diseases Control and Prevention Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Weekly Rep 2007, 56:332-336.
71. Centers for Diseases Control and Prevention Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Weekly Rep 2012, 61:590-594.
72. Tsai CH, Lee TC, Chang HL, et al. The cost-effectiveness of syndromic management for male sexually transmitted disease patients with urethral discharge symptoms and genital ulcer disease in Taiwan. Sex Transm Infect 2008, 84:400-404.
73. Wikstrom A, Jensen JS Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006, 82:276-279.
74. Maeda SI, Tamaki M, Kojima K, et al. Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. Sex Transm Dis 2001, 28:472-476.
75. Hooton TM, Wong ES, Barnes RC, et al. Erythromycin for persistent or recurrent nongonococcal urethritis: a randomized placebo-controlled trial. Ann Intern Med 1990, 113:21-26.
76. Berger RE Recurrent nongonococcal urethritis. JAMA 1983, 249:409.
77. Crombleholme WR, Schachter J, Grossman M, et al. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol 1990, 75:752-756.
78. Campbell WR, Dodson MG Clindamycin therapy for Chlamydia trachomatis in women. Am J Obstet Gynecol 1990, 162:343-347.
79. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005, 41:623-629.
80. Schneider JM, Matthews JH, Graham BS Reiter's syndrome. Cutis 2003, 71:198-200.
81. Keat A Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983, 309:1606-1615.
82. Arnett FC Reiter's syndrome. Johns Hopkins Med J 1982, 150:39-44.
83. Wu IB, Schwartz RA Reiter's syndrome: the classic triad and more. J Am Acad Dermatol 2008, 59:113-121.
84. Sampaio-Barros PD, Conde RA, Donadi EA, et al. Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int 2008, 28:483-486.
85. Hawkes JG Clinical and diagnostic features of Reiter's disease: a follow-up study of 39 patients. N Z Med J 1973, 78:347-353.
86. Leirisalo M, Skylv G, Kousa M, et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982, 25:249-259.
87. Ozgul A, Dede I, Taskaynatan MA, et al. Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol Int 2006, 26:879-885.
88. Keat AC, Thomas BJ, Taylor-Robinson D, et al. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980, 39:431-437.
89. Kousa M Evidence of chlamydial involvement in the development of arthritis. Scand J Infect Dis 1982, 32(suppl):116-121.
90. Inman RD, Johnston MEA, Chiu B, et al. Immunochemical analysis of immune response to Chlamydia trachomatis in Reiter's syndrome and nonspecific urethritis. Clin Exp Immunol 1987, 69:246-254.
91. Hughes RA, Keat AC Reiter's syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 1994, 24:190-210.
92. Taylor-Robinson D, Gilroy CB, Thomas BJ, et al. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992, 340:81-82.
93. Keat A, Dixey J, Sonnex C, et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987, 1:72-75.
94. Hayward RS, Wensel RH, Kibsey P Relapsing Clostridium difficile colitis and Reiter's syndrome. Am J Gastroenterol 1990, 85:752-756.
95. Cron RQ, Sherry DD Reiter's syndrome associated with cryptosporidial gastroenteritis. J Rheumatol 1995, 22:1962-1963.
96. Scofield RH, Kurien B, Gross T, et al. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995, 345:1542-1544.
97. Kobayashi S, Ogasawara M, Maeda K, et al. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome. J Lab Clin Med 1985, 105:380-389.
98. Weinberger HW, Ropes MW, Kulka JP, et al. Reiter's syndrome, clinical and pathologic observations: a long term study of 16 cases. Medicine (Baltimore) 1962, 41:35-91.
99. Kaye BR Rheumatologic manifestations of HIV infections. Clin Rev Allergy Immunol 1996-7, 14:385-416.
100. Good AE Reiter's disease. Postgrad Med 1977, 61:153-158.
101. Marks JS, Holt PJL The natural history of Reiter's disease: 21 years of observations. Q J Med 1986, 60:685-697.
102. Lyons JL, Rosenbaum JT Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997, 115:61-64.
103. Daunt SO, Kotowski KE, O'Reilly AP, et al. Ulcerative vulvitis in Reiter's syndrome: a case report. Br J Vener Dis 1982, 58:405-407.
104. Arnett FC, McClusky OE, Schacter BZ, et al. Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med 1976, 84:8-12.
105. Csonka GW Recurrent attacks in Reiter's disease. Arthritis Rheum 1960, 3:164-169.
106. Bardin T, Schumacher HR Should we treat postvenereal Reiter's syndrome by antibiotics? [editorial]. J Rheumatol 1991, 18:1780-1781.
107. Ford DK Reiter's syndrome: current concepts of etiology and pathogenesis. Nongonococcal Urethritis and Related Infections 1977, 64-66. American Society for Microbiology, Washington, DC. D. Hobson, K.K. Holmes (Eds.).
108. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992, 35:190-194.
109. Lauhio A, Leirisalo-Repo M, Lähdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991, 34:6-14.
110. Toussirot E, Despaux J, Wending D Do minocycline and other tetracyclines have a place in rheumatology?. Rev Rhum Engl Ed 1997, 64:474-480.
111. Treating Reiter's syndrome [editorial]. Lancet 1987, 2:1125-1126.
112. Gill H, Majithia V Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion. Clin Rheumatol 2008, 27:121-123.
113. Taylor-Robinson D The history of nongonococcal urethritis. Thomas Parran Award Lecture. Sex Transm Dis 1996, 23:86-91.
114. Geisler WM, Yu S, Hook EW Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on Gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005, 32:630-634.
115. Jacobs NF, Kraus SJ Gonococcal and nongonococcal urethritis in men: clinical and laboratory differentiation. Ann Intern Med 1975, 82:7-12.
116. Krieger JN, Verdon M, Siegel N, et al. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992, 166:1362-1366.
117. Krieger JN, Jenny C, Verdon M, et al. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993, 118:844-849.
118. Schwebke J, Hobbs M, Taylor S, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective US clinical trial. J Clin Microbiol 2001, 49:4106-4111.
119. Horner PJ, Taylor-Robinson D Is there a role for leucocytes esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men?. Int J STD AIDS 2007, 18:73-74.
120. Jaschek G, Gaydos CA, Welsh LE, et al. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993, 31:1209-1212.
121. Chernesky M, Jang D, Chong S, et al. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infection in men. Sex Transm Dis 2003, 30:345-347.
122. Martin DH Nongonococcal urethritis: new views through the prism of modern molecular microbiology. Curr Infect Dis Rep 2008, 10:128-132.
123. Augenbraun MH, Cummings M, McCormack WM Management of chronic urethral symptoms in men. Clin Infect Dis 1992, 15:714-715.
124. Stamm WE, Koutsky LA, Benedetti JK, et al. Chlamydia trachomatis urethral infections in men: prevalence, risk factors, and clinical manifestations. Ann Intern Med 1984, 100:47-51.
125. Boyd JT, Csonka GW, Oates JK Epidemiology of non-specific urethritis. Br J Vener Dis 1958, 34:40-43.
126. Rothenberg R, Judson FN The clinical diagnosis of urethral discharge. Sex Transm Dis 1983, 10:24-28.
127. Lee Y-H, Rosner B, Alpert S, et al. Clinical and microbiological investigation of men with urethritis. J Infect Dis 1978, 138:798-803.
128. Holmes KK Gonococcal infection: clinical, epidemiologic and laboratory perspectives. Adv Intern Med 1974, 19:259-285.
129. Bradshaw C, Tabrizi S, Read T, et al. Etiologies of nongonococcal urethritis: bacteria, viruses and the association with orogenital exposure. J Infect Dis 2006, 193:336-345.
130. Yoshida T, Deguchi T, Meda S, et al. Quantitative detection of Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens from men with and without urethritis by real-time polymerase chain reaction. Sex Transm Dis 2007, 34:416-419.
131. Taylor-Robinson D, McCormack WM The genital mycoplasmas. N Engl J Med 1980, 302:1003-1010.
132. Tully JG, Cole RM, Taylor-Robinson D, et al. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981, 1:1288-1291.
133. Manhart L, Broad J, Golden M Mycoplasma genitalium: should we treat and how?. Clin Infect Dis 2011, 53(suppl 3):S129-S142.
134. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infection: clinical manifestations, course, and complications. Ann Intern Med 1983, 98:958-972.
135. Wendel KA, Erbelding EJ, Gaydos CA, et al. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect 2003, 79:151-153.
136. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006, 193:336-345.
137. Handsfield HH Nongonococcal urethritis: a few answers but mostly questions. J Infect Dis 2006, 193:333-335.
138. Yokoi S, Maeda S, Kubota Y, et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007, 45:866-871.
139. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984, 310:545-549.
140. Handsfield HH, Lipman TO, Harnisch JP, et al. Asymptomatic gonorrhea in men: diagnosis, natural course, prevalence and significance. N Engl J Med 1974, 290:117-123.
141. Detels R, Green A, Klausner J, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis 2011, 38:503-509.
142. Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980, 303:409-414.
143. Berger RE Acute epididymitis. Sex Transm Dis 1981, 8:286-289.
144. Holmes KK, Hansfield HH, Wang SP, et al. Etiology of nongonococcal urethritis. N Engl J Med 1975, 292:1199-1205.
145. Krieger JN, Riley DE Chronic prostatitis: Charlottesville to Seattle. J Urol 2004, 172:2557-2560.
146. Augenbraun M, Bachmann L, Wallace T, et al. Compliance with doxycycline therapy in sexually transmitted disease clinics. Sex Transm Dis 1998, 25:1-4.
147. Centers for Diseases Control and Prevention Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Weekly Rep 2012, 61:590-594.
148. Berger RE Recurrent nongonococcal urethritis. JAMA 1983, 249:409.
149. Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005, 41:623-629.
150. Keat A Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983, 309:1606-1615.
151. Sampaio-Barros PD, Conde RA, Donadi EA, et al. Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int 2008, 28:483-486.
152. Keat AC, Thomas BJ, Taylor-Robinson D, et al. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980, 39:431-437.
153. Hughes RA, Keat AC Reiter's syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 1994, 24:190-210.
154. Taylor-Robinson D, Gilroy CB, Thomas BJ, et al. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992, 340:81-82.
155. Weinberger HW, Ropes MW, Kulka JP, et al. Reiter's syndrome, clinical and pathologic observations: a long term study of 16 cases. Medicine (Baltimore) 1962, 41:35-91.
156. Marks JS, Holt PJL The natural history of Reiter's disease: 21 years of observations. Q J Med 1986, 60:685-697.
157. Csonka GW Recurrent attacks in Reiter's disease. Arthritis Rheum 1960, 3:164-169.
158. Bardin T, Schumacher HR Should we treat postvenereal Reiter's syndrome by antibiotics? [editorial]. J Rheumatol 1991, 18:1780-1781.
159. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992, 35:190-194.